See more : Adevinta ASA (ADEO.OL) Income Statement Analysis – Financial Results
Complete financial analysis of Upstart Holdings, Inc. (UPST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Upstart Holdings, Inc., a leading company in the Financial – Credit Services industry within the Financial Services sector.
You may be interested
- Suzhou Novosense Microlectronics (688052.SS) Income Statement Analysis – Financial Results
- Bosideng International Holdings Limited (3998.HK) Income Statement Analysis – Financial Results
- Aster DM Healthcare Limited (ASTERDM.BO) Income Statement Analysis – Financial Results
- Hulic Co., Ltd. (3003.T) Income Statement Analysis – Financial Results
- Higgstec Inc. (5220.TWO) Income Statement Analysis – Financial Results
Upstart Holdings, Inc. (UPST)
About Upstart Holdings, Inc.
Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform aggregates consumer demand for loans and connects it to its network of the company's AI-enabled bank partners. The company was founded in 2012 and is headquartered in San Mateo, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 513.56M | 853.29M | 851.86M | 241.44M | 190.67M | 125.80M | 66.71M |
| Cost of Revenue | 24.90M | 187.99M | 117.58M | 37.58M | 24.95M | 15.42M | 10.23M |
| Gross Profit | 488.66M | 665.29M | 734.28M | 203.86M | 165.73M | 110.38M | 56.48M |
| Gross Profit Ratio | 95.15% | 77.97% | 86.20% | 84.43% | 86.92% | 87.75% | 84.66% |
| Research & Development | 280.14M | 237.25M | 134.00M | 38.80M | 18.78M | 8.42M | 5.32M |
| General & Administrative | 212.39M | 185.29M | 121.44M | 45.61M | 31.87M | 19.82M | 15.43M |
| Selling & Marketing | 127.14M | 345.78M | 333.45M | 99.66M | 93.18M | 63.63M | 33.84M |
| SG&A | 339.53M | 531.07M | 454.89M | 145.27M | 125.04M | 83.45M | 49.27M |
| Other Expenses | 150.42M | 9.47M | -5.17M | 5.55M | 1.04M | 487.00K | 330.00K |
| Operating Expenses | 770.09M | 773.00M | 597.31M | 190.13M | 145.22M | 95.12M | 55.91M |
| Cost & Expenses | 770.09M | 960.99M | 714.88M | 227.72M | 170.17M | 110.53M | 66.14M |
| Interest Income | 169.00M | 105.58M | 47.31M | 4.82M | 63.31M | 76.68M | 21.13M |
| Interest Expense | 34.89M | 10.84M | 3.27M | 8.03M | 26.49M | 26.48M | 9.42M |
| Depreciation & Amortization | 24.90M | 13.51M | 7.54M | 2.28M | 774.00K | 314.00K | 93.00K |
| EBITDA | -215.12M | -89.51M | 140.88M | 11.77M | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | -41.89% | -10.49% | 17.95% | 9.14% | 11.90% | 14.97% | 2.96% |
| Operating Income | -256.52M | -103.02M | 145.39M | 19.79M | 21.91M | 18.51M | 1.88M |
| Operating Income Ratio | -49.95% | -12.07% | 17.07% | 8.20% | 11.49% | 14.72% | 2.82% |
| Total Other Income/Expenses | 16.50M | 4.79M | -7.15M | -5.82M | -4.95M | -11.22M | -8.86M |
| Income Before Tax | -240.03M | -109.07M | 133.73M | 5.95M | -4.95M | -11.22M | -8.86M |
| Income Before Tax Ratio | -46.74% | -12.78% | 15.70% | 2.46% | -2.59% | -8.92% | -13.27% |
| Income Tax Expense | 107.00K | 409.00K | 1.71M | 371.00K | 74.00K | 1.10M | 6.00K |
| Net Income | -240.13M | -108.67M | 135.44M | 5.98M | -466.00K | -12.32M | -7.72M |
| Net Income Ratio | -46.76% | -12.73% | 15.90% | 2.48% | -0.24% | -9.79% | -11.57% |
| EPS | -2.87 | -1.31 | 1.73 | 0.08 | -0.01 | -0.87 | -0.56 |
| EPS Diluted | -2.87 | -1.31 | 1.43 | 0.08 | -0.01 | -0.87 | -0.56 |
| Weighted Avg Shares Out | 83.77M | 82.77M | 78.11M | 73.31M | 73.31M | 14.13M | 13.87M |
| Weighted Avg Shares Out (Dil) | 83.77M | 82.77M | 94.77M | 73.31M | 73.31M | 14.13M | 13.87M |
Could Buying Upstart Stock Today Set You Up for Life?
Shares have soared 45% just in the past couple of months.
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
Viking Therapeutics stock is on the rise as the battle to develop new weight-loss drugs heats up. Here's what's at stake for the pharma giants fighting for position.
The Federal Reserve Is Cutting Interest Rates: 3 Stocks to Buy Today
With interest rates set to fall over the next year, these three stocks could be smart buys today.
Upstart Holdings, Inc. (UPST) Flat As Market Sinks: What You Should Know
In the closing of the recent trading day, Upstart Holdings, Inc. (UPST) stood at $38.94, denoting no change from the preceding trading day.
2 Stocks Down 88% and 90% to Buy Right Now
These fintech stocks look ready for a rebound.
MIT Federal Credit Union Selects Upstart for Personal Lending
LEXINGTON, Mass. & SAN MATEO, Calif.--(BUSINESS WIRE)--MIT Federal Credit Union Selects Upstart for Personal Lending.
Interest Rate Cuts Are Terrific News for These 2 Stocks, But Terrible News for Another
The Federal Reserve slashed the fed funds rate last month, and more cuts are likely on the way.
Lucid Group: Continued Liquidity Dip Sets Up Precarious Drive For This EV Upstart
Lucid Group's deliveries and revenue have grown, but they fall short of early guidance, reflecting a reset of expectations amid a challenging macro environment. The company faces significant cash burn, with a negative free cash flow of $41.3 million in...
Down 90% From the Highs, This Stock Could Be a Big Winner of the Fed's Rate Cut
This fintech disruptor has already rebounded sharply, but it could be just the beginning.
Watch These 3 Former Short-Squeeze Stocks for a Big Rally
In recent years, high short-interest stocks have become the playground for retail traders and investors, leading to massive rallies and squeezes. These speculative names, driven by a combination of social media buzz and perceived market inefficiencies, showcase extreme volatility, providing...
Source: https://incomestatements.info
Category: Stock Reports